Ocelot Bio brings new treatment options to patients with severe liver disease.
Ocelot Bio has raised $3.0M in total funding. The most recent round was Debt Financing. The last funding was announced in July 2023.
Ocelot Bio's investors include RA Capital Management, Vivo Capital, Venrock.
Ocelot Bio is headquartered in San Diego, United States.
Ocelot Bio brings new treatment options to patients with severe liver disease.
Ocelot Bio is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ocelot Bio — Funding & Investors." VCBacked, July 12, 2023, https://www.vcbacked.co/company/ocelot-bio. Accessed July 20, 2026.
VCBacked. (2023). Ocelot Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ocelot-bio
{{cite web |title=Ocelot Bio — Funding & Investors |url=https://www.vcbacked.co/company/ocelot-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated